A Multicenter,Randomized,Double-blind Clinical Study on Wufuxinnaoqing Soft Capsule(五福心脑清胶囊) in Treatment of Chronic Stable Angina Patients with Blood Stasis Syndrome

Objective:To confirm the efficacy and safety of Wufuxinnaoqing Soft Capsule(五福心脑清胶囊,WSC)in the treatment of chronic stable angina(blood stasis syndrome).Methods:A multicenter,randomized,double-blind,placebo-controlled trial with superiority test was designed.A total of 240 patients with chronic stable angina(blood stasis syndrome)from multiple centers were randomly and equally assigned to the treatment group and the control group.Based on standard treatment of Westem medicine,the treatment group was given WSC,while the control group was given WSC mimetic,both for 12 weeks.Observed indicators included the efficacy in angina,the efficacy in Chinese medicine syndrome,the withdrawal or reduce rate of nitroglycerin and routine safety indices.Results:After 12-week treatment,the significant effective rate and total effective rate of the treatment group were significantly better than those of the control group(23.5%vs.9.2%,64.7%vs.30.8%),respectively,with statistically significant difference(P0.01).After 12-week treatment,the decreased points and the decreased rate of angina symptom score in the treatment group were better than in the control group(5.1±4.2 points vs.2.8±3.5 points,44.9%±37.2%vs.25.4%±30.7%)respectively,with significant difference(P0.01).After 12-week treatment,the significant effective rate and total effective rate of the treatment group were better than the control group(respectively,30.3%vs.15.0%,67.2%vs.45.0%,P0.01).After 8-or 12-week treatment,the decreased points and the decreased rate of Chinese medicine syndrome score in the treatment group were better than the control group(P0.05 or P0.01).After 12-week treatment,nitroglycerin withdrawal rate and the withdrawal or reduce rate in treatment group were better than the control group(P0.01).On safety evaluation,the incidence of adverse events(7.563%vs.7.500%)and the incidence of cardiovascular events(0.840%vs.0.000%)in the treatment group were similar with the control group,and the difference was not statistically significant(P0.05).Conclusion:In treatment of chronic stable angina(blood stasis syndrome),WSC can reduce angina attacks and consumption of nitroglycerin,decrease angina severity degree,effectively relieve the blood stasis syndromes,such as chest pain,chest tightness,palpitations,dark purple tongue and other symptoms.Besides,adverse events and cardiovascular adverse events in the treatment group and the control group showed no difference.All shows that the drug is safe and effective.[This study was registered in Chinese Clinical Trial Registry(ChiCTR),with registration number:ChiCTR-TRC-14005158.]     

老年糖尿病低血糖的预防及护理体会

目的：探讨老年糖尿病患者低血糖反应的临床特征及护理对策。方法对本院自2010年1月-2011年1月诊治的32例老年性糖尿病低血糖患者的临床资料进行回顾性分析。结果本组32例患者经系统的护理干预均好转,且无患者发生并发症。结论护理人员熟练掌握低血糖反应的相关知识,同时具备鉴别及处理低血糖症状的能力,并给予患者系统的护理干预可有效的预防及减少老年糖尿病患者低血糖现象的发生。     

幽门螺杆菌相关性胃溃疡胃癌组织中VEGF的表达及意义

目的:研究幽门螺杆菌(HP)感染与胃溃疡、胃癌组织中血管内皮生长因子(VEGF)表达的关系及意义.方法:应用免疫组化SABC法检测36例胃溃疡、52例胃癌组织中HP及VEGF的表达.结果:胃溃疡组织中HP阳性组的VEGF表达(53.6%)明显高于HP阴性组(12.5%),两组间比较有显著性差异(P＜0.05);胃癌组织中HP阳性组的VEGF表达(84%)明显高于HP阴性组(40.7%),两组间比较差异显著(P＜0.05).结论:HP感染可增加VEGF的表达,HP阳性组胃溃疡组织中VEGF表达可能与胃溃疡发病的时段有关.     

从痰论治冠心病心绞痛探析

从冠心病从痰论治的理论基础、从祛痰治疗冠心病能获得的益处对从痰论治冠心病心绞痛作了探析。指出：痰瘀症候与脂蛋白代谢存在密切关系,而冠心痛与中医的痰凝血瘀有关,化痰类药物的确能增加冠状动脉血流量,增加心肌收缩力,降脂提高心肌核酸代谢,保护缺血心肌。     

从肝论治胸痹探要

从肝与心的生理联系、病因病机论述从肝论治胸痹。治宜疏肝与柔肝,疏之以刚克柔,柔之以柔克刚。用辛以助其条达之性,起到疏肝作用;用酸以抑其上逆之性,起到了柔肝的作用。     

加味大柴胡汤对动脉粥样硬化家兔主动脉细胞间黏附分子-1、核因子-κB表达的影响

目的：探讨加味大柴胡汤抗动脉粥样硬化（artheroscerosis,AS）的机制。方法：随机将50只家兔分为空白对照组、模型组、加味大柴胡汤预防组（预防组）、血脂康组、加味大柴胡汤治疗组（治疗组）。测定各组家兔血清总胆固醇（total cholesterol,TC）、三酰甘油（triglyceride,TG）、低密度脂蛋白胆固醇（low density lipoprotein—cholesterol,LDL—C）、高密度脂蛋白胆固醇（highdensity lipoprotein—cholesterol,HDL-C）水平;采用RT-PCR和Western方法检测兔主动脉细胞间黏附分子-1（intracellular adhesion molecule-1,ICAM—1）、核因子-κB（nuclear factor-κB,NF—κB）mRNA和蛋白表达。结果：①与治疗组比较,血脂康组、预防组TC、TG、LDL—C和HDL-C显著降低（P〈0．01）;②与血脂康组、治疗组比较,预防组ICAM—1、NF—κB mRNA和蛋白表达水平显著降低（P〈0．05）。结论：加味大柴胡汤抗AS作用与其降低血脂及抑制主动脉ICAM—1、NF-κB表达有关。     

E2F3,MCM2及HIF-1α在结直肠癌中的表达及其相关性

目的:探讨转录因子E2F3、微型染色体维持蛋白(minichromosome maintenance proteins 2,MCM2)及缺氧诱导因子1a(hypoxia-induciblefactor 1α,HIF-1α)在结直肠癌、结直肠腺瘤、大肠正常黏膜组织中的表达及他们与结直肠癌临床病理因素之间的关系.方法:收集...     

羧乙基锗倍半氧化物对实验诱发小鼠前胃癌变过程中的免疫作用

Ｎ—亚硝基肌氨酸乙酯（ＮＳＥＥ）诱发昆明小鼠前胃癌变，再以羧乙基锗倍半氧化物（Ｇｅ－１３２）治疗结果发现实验组中癌细胞的浸润深度显著浅于对照组（Ｐ＜０．０５）；实验组核仁组成区相关嗜银蛋白（ＡｇＮＯＲ）计数及细小、不规则颗粒所占比例均低于对照组（Ｐ＜０．０５）；实验组癌周淋巴细胞浸润反应则较对照组显著（Ｐ＜０．０５）。提示Ｇｅ－１３２对ＮＳＥＥ诱发的小鼠前胃癌有一定的治疗作用；并从免疫形态学证实介导宿主免疫反应可能是Ｇｅ－１３２发挥抗癌作用的机制之一。本研究为Ｇｅ－１３２用于临床提供理论依据。     

雌性激素诱发的小鼠垂体肿瘤细胞化学和电镜观察

本文用细胞化学染色和电子显微镜将雌性激素诱发的小鼠垂体肿瘤进行了分类: 用苏木精一伊红常规染色,全部垂体肿瘤似乎是嗜碱性腺瘤或腺癌,而用Herlant阿利新兰—PAS—金橙G染色确证是嗜酸性细胞肿瘤,其胞浆呈橙黄色。 在电镜观察下进一步将其分类为分泌催乳激素的肿瘤,其胞浆含有大的分泌颗粒,其颗粒大小不一、形状不规则(圆形、椭圆形、多角形等)。     

切扩加消痔灵注射治疗肛裂1160例

对1160例各期肛裂,施行内括约肌侧切扩肛加消痔灵注射治疗,治愈1144例,治愈率98％,好转12例,4例无效。认为此法治疗肛裂有迅速解除痛苦,疗程短,远期疗效好等优点。